Team-Based Oncology Care Findings at ASCO Quality 2022

Aaron Galaznik from Carevive attended the ASCO Quality Symposium in Chicago alongside Robin Richardson from the Livestrong Cancer Institute at UT Austin. They shared insights into their research on measuring the effectiveness of a team-based oncology care approach for palliative patient care. The study involved an extensive analysis of every patient’s medical records since the clinic’s opening. The findings were astonishing and highlighted the success of their model in delivering integrated care while identifying areas for improvement.

Key Research Findings:
The Livestrong Cancer Institute’s research revealed that nearly 80% of metastatic patients received at least two palliative care touchpoints, a significantly higher rate compared to the average of 2% found in existing literature. This demonstrated the efficacy of their team-based approach in reaching patients and providing comprehensive care. Additionally, the study focused on patient-reported outcomes (PROs) and identified that 86% of patients with severe physical symptoms received a relevant provider’s attention within a week. While this rate was commendable, the aim is to further improve and achieve 100% timely interventions, with the ultimate goal of reducing response time to less than 24 hours.

Recent Episodes

In this episode of Care Anywhere: The Global Health Workforce Podcast, host Lea Sims welcomes Syl Trepanier, DNP, RN, Chief Nursing Officer for Providence Health and member of the TruMerit Board of Trustees. With responsibility for representing more than 36,000 nurses across a multi-state health system, Syl shares his personal journey from caregiving as…

The accelerator model is undergoing a transformation, and at the center of this change is HealthTech Arkansas, a powerful program that’s redefining the traditional approach by guaranteeing clinical pilots for healthcare startups. As the healthcare system faces a mounting burden from chronic disease (cardiovascular-related costs alone are projected to reach a staggering $1.8 trillion…

Michael Rothman explores the complexities of sepsis identification and management, highlighting the challenges posed by varying definitions and clinical pathways. He discusses the ineffectiveness of current sepsis screening protocols, which often yield high false-positive rates and fail to reduce mortality meaningfully. The episode concludes by questioning the focus on sepsis-specific initiatives and suggesting that more…